References: 1. Stark A. Remarks from FDA Commissioner Scott Gottlieb, M.D., as prepared for delivery at the Brookings Institution on the release of the FDA’s Biosimilars Action Plan. US Food and Drug Administration (FDA). July 18, 2018. Accessed March 2, 2023. https://www.fda.gov/news-events/press-announcements/remarks-fda-commissioner-scott-gottlieb-md-prepared-delivery-brookings-institution-release-fdas 2. US Food and Drug Administration. Biosimilars action plan: balancing innovation and competition. July 2018. Accessed March 2, 2023. https://www.fda.gov/media/114574/download 3. Biosimilar and interchangeable biologics: more treatment choices. US Food and Drug Administration. Updated October 12, 2021. Accessed March 16, 2023. https://www.fda.gov/consumers/consumer-updates/biosimilar-and-interchangeable-biologics-more-treatment-choices